论文部分内容阅读
为适应HbA1c临床应用发展的需要,提高HbA1c的测定质量,卫生部临床检验中心等多家机构和医院的检验学与临床专家根据我国HbA1c检测现状并结合国内外相关理念共识和研究进展,制定了《糖化血红蛋白测定专家共识》(以下简称“共识”)。尽管我国在临床上HbA1c尚未被用于糖尿病诊断,但在检验科医师们的眼中,HbA1c有着诸多优势,必然会替代传统的血浆或血清血糖测定。下面就让我们听一听检验科专家是怎么说的吧。随着分级诊疗的推广,HbA1c或许应当得到过多的关注。
In order to meet the needs of the development of HbA1c clinical application and to improve the quality of HbA1c assay, the laboratory and clinical experts of many institutions and hospitals such as the Clinical Laboratory of the Ministry of Health have formulated the HbA1c test status in China based on the consensus of the relevant concepts at home and abroad, “Glycated hemoglobin determination expert consensus” (hereinafter referred to as “consensus ”). Although HbA1c has not been clinically used in the diagnosis of diabetes, HbA1c has many advantages in the eyes of laboratory physicians and will inevitably replace traditional plasma or serum glucose measurement. Let’s listen to what a laboratory specialist is saying below. With the promotion of grading treatment, HbA1c may deserve too much attention.